Clinicore
CJC-1295 with DAC 5mg – Research Peptide Vial | CLINICORE Peptides
CJC-1295 with DAC 5mg – Research Peptide Vial | CLINICORE Peptides
Couldn't load pickup availability
CJC-1295 with DAC 5mg Research Peptide Vial
Lyophilised CJC-1295 with DAC supplied as a 5mg vial with defined analytical specifications for controlled laboratory research use.
CLINICORE CJC-1295 with DAC 5mg research peptide is supplied as a white to off white lyophilised powder in a single vial format for laboratory and analytical workflows. This CJC-1295 with DAC peptide vial is intended for in vitro research environments where consistent presentation and documented specifications are required.
Overview
CJC-1295 with DAC is supplied by CLINICORE Peptides as a white to off white lyophilised powder in a single vial format. This CJC-1295 with DAC research peptide listing supports laboratory workflows where documented identity and consistent handling are required.
Handling and solubility
This section provides CJC-1295 with DAC handling and solubility information for laboratory workflows. Handle using appropriate laboratory PPE and standard laboratory safety protocols.
CJC-1295 with DAC peptide powder is soluble in sterile water or bacteriostatic water for research use only. Reconstitute gently using controlled swirling.
Storage guidelines
These CJC-1295 with DAC storage guidelines apply to lyophilised research peptides. Store lyophilised powder at -20°C, protected from light and moisture.
After reconstitution, store at 2–8°C and use within 14 days.
Intended use
This CJC-1295 with DAC research peptide is supplied strictly for laboratory research use only. It is not intended for human or veterinary use and is not approved for diagnostic, therapeutic, or medical applications. Handle following appropriate laboratory safety protocols.
CLINICORE quality and assurance
CLINICORE Peptides maintains a controlled, specification driven approach to research supply. Each CJC-1295 with DAC vial is presented with clearly defined identity and quality markers including stated content, appearance, and reported analytical purity to support consistent laboratory documentation and reproducible handling.
If additional documentation is required for internal QC or research records, please contact the CLINICORE team prior to use so we can advise what information may be available.
Share
